240 mL Water Drink Study

July 3, 2013 updated by: University of Nottingham

MRI Quantification of Gastric and Small Bowel Liquid Volumes Before and After Ingestion of the Standard Oral Solid Delivery 240 mL Water Drink

The GI MRI Research group at the University of Nottingham has been developing new, non-invasive magnetic resonance imaging (MRI) techniques to image the gastrointestinal tract. The investigators now want to characterise; in collaboration with the College of Pharmacy at the University of Michigan, the fasting volumes of gastric and small bowel liquid and their time courses over 2 hours after drinking the FDA recommended 240 mL of water drink for oral solid dosage forms testing.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Solid oral delivery is the most frequently used route of administration for pharmaceutical drug products. Along with other important physiological parameters, the volume of liquid in the small intestine (SILV) has the potential to greatly influence the rate and extent of drug dissolution and absorption in the GI tract, or "oral bioperformance". Modeled small bowel absorption of a drug can vary by more than five-fold as SILV decreases from 500 to 50 ml. To obtain reasonable predictions of oral bioperformance scientists must design meaningful in vitro dissolution tests and mechanistic drug transport models that capture the range of SILV in humans. However, little is known about liquid volumes in the gut, mostly due to invasiveness of previous techniques. A recent study has drawn great attention to the possibility of the liquid in the small intestine existing in discrete liquid "pockets" hence it would also be desirable to monitor the time courses and volumes of individual water pockets in the small intestine.

Magnetic resonance imaging (MRI) is the ideal tool to carry out serial and non-invasive imaging of gastrointestinal function. MRI is inherently suited to image liquid materials and this ability has been exploited to image liquids in the undisturbed gastrointestinal tract. Gastric emptying measurements have been long established and validated. Small bowel liquid volumes measurements have been recently validated against naso-duodenal infusion. Ultimately, the findings with this study will provide novel insights on the volume and distribution of ingested liquids in the gastrointestinal tract.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom, NG7 2RD
        • University of Nottingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Apparently healthy; no medical conditions that might affect the study measurements
  • Male or female
  • Age between 18 and 55 years of age
  • Body mass index (BMI) between 18.5 and 24.9 kg m-2
  • Suitable for MRI scanning (eg absence of metal implants, infusion pumps and pacemakers as assessed by the MRI safety questionnaire

Exclusion Criteria:

  • Previous gastrointestinal surgery (excluding cholecystectomy and appendectomy)
  • Known gastrointestinal disease
  • Smoking
  • History of alcohol or drug abuse
  • Taking medication that is likely to affect gastrointestinal function
  • Participation in night shift work the week prior to the study day. (Night work is defined as working between midnight and 6 am)
  • Strenuous exercise greater than 10 hours per week
  • Consumption of more than 21 units of alcohol in a typical week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 240 mL water drink
Volunteers will be asked to drink 240 mL water drink

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time course of small bowel liquid volume after ingesting 240 mL of water
Time Frame: 0 - 120 mins
Time course for the volume of freely mobile water in the small bowel over 2 hours
0 - 120 mins

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time course of gastric liquid volume after ingesting 240 mL of water
Time Frame: 0 - 120 mins
Gastric volumes obtained from MRI as a function of time
0 - 120 mins
Number of liquid pockets in the small bowel
Time Frame: 0 - 120 mins
Assessment of the number of pockets of liquid in the small bowel as seen on the MR images
0 - 120 mins
Volume of liquid pockets in the small bowel
Time Frame: 0 - 120 mins
The volume of freely mobile liquid in each of the liquid pockets identified on the MR image
0 - 120 mins
Summary information on the location of liquid pockets by quadrant
Time Frame: 0 - 120 mins
Details on the distribution of the liquid pockets as seen on the MR images
0 - 120 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kathryn Murray, PhD, University of Nottingham
  • Principal Investigator: Caroline Hoad, PhD, University of Nottingham
  • Principal Investigator: Penny Gowland, PhD, University of Nottingham
  • Principal Investigator: Susan Pritchard, MSc, University of Nottingham
  • Principal Investigator: Martin Garnett, University of Nottingham
  • Principal Investigator: Robin Spiller, FRCP, University of Nottingham
  • Principal Investigator: Gregory Amidon, University of Michigan
  • Principal Investigator: Gordon Amidon, University of Michigan
  • Principal Investigator: Deanna Mudie, University of Michigan
  • Study Director: Luca Marciani, PhD, University of Nottingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

March 1, 2013

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

February 13, 2013

First Submitted That Met QC Criteria

February 13, 2013

First Posted (Estimate)

February 15, 2013

Study Record Updates

Last Update Posted (Estimate)

July 4, 2013

Last Update Submitted That Met QC Criteria

July 3, 2013

Last Verified

July 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • A10012013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Spring water

Subscribe